The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.
Jeanne Kay Whitefeather, 62, testified in her own defense Tuesday afternoon, Jan. 21, 2025, as the trial for child abuse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback